Acadia Pharma GAAP EPS of $1.60 beats by $1.46, revenue of $284M misses by $8.59M Posted on February 25, 2026 by wpadmin Acadia Pharma press release (ACAD): Q4 GAAP EPS of $1.60 beats by $1.46. Revenue of $284M (+9.4% Y/Y) misses by $8.59M.